Efficacy and Safety of 3% Minoxidil Lotion for Beard Enhancement

Efficacy and Safety of 3% Minoxidil Lotion for Beard Enhancement : A Randomized, Double-blind, Placebo-controlled Study

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02275832

Enrollment

Registered

2014-10-27

Start date

2014-11-30

Completion date

2015-03-31

Last updated

2015-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Beard Enhancement

Brief summary

The purpose of this study is to determine efficacy and safety of 3% minoxidil lotion for beard enhancement.

Interventions

DRUG3 % Minoxidil lotion

DRUGPlacebo

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

MALE

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy male

Exclusion criteria

* serious underlying diseases. * history of beard/ hair treatment before 6 months * history of surgery or trauma on beard area. * history of minoxidil allergy

Design outcomes

Primary

Measure	Time frame
The change of global photographic assessment after 16 weeks from baseline	baseline and 16 weeks

Secondary

Measure	Time frame
The change in number of hairs after 16 weeks from baseline	baseline and 16 weeks

Other

Measure	Time frame
The change of hair diameter after 16 weeks from baseline	baseline and 16 weeks
Number of participants with adverse events	baseline and 16 weeks
Patient satisfaction by self-assessment questionnaires	baseline and 16 weeks

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026